ASH 2013
Interviews and expert commentary tagged “ASH 2013” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Chimeric antigen receptor T-cell therapy: high remission rate in relapsed, refractory acute lymphoblastic leukemia
NEW ORLEANS—High remission rates with extended survival are being achieved in patients who had failed all other therapies — including allogeneic stem cell transplantation — for their acute lymphoblast
19 December 2013
0:00